发明申请
- 专利标题： COMPOSITIONS FOR TREATING PSORIASIS
- 专利标题（中）： 用于处理PSORIASIS的组合物
-
申请号： US12979081申请日： 2010-12-27
-
公开(公告)号： US20110091472A1公开(公告)日： 2011-04-21
- 发明人: Keting Chu , Changyu Wang
- 申请人： Keting Chu , Changyu Wang
- 申请人地址： US CA Emeryville
- 专利权人： Novartis Vaccines and Diagnostic, Inc.
- 当前专利权人： Novartis Vaccines and Diagnostic, Inc.
- 当前专利权人地址： US CA Emeryville
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; A61P17/06
摘要：
CD40 antagonists are used to prepare compositions, including pharmaceutical compositions, for treating autoimmune and neoplastic diseases in a mammal. The CD40 antagonist compositions are useful for reversing or substantially diminishing such autoimmune diseases as systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis and psoriasis.